Search results

Page results

• Molecular Radiotherapy Series No. 6 - Information for parents of children and young people having radioactive iodine (131I) treatment

  This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.

• Towards net zero - education and engagement

  Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.

• Guy Noble - arts curator

  Art and creativity can be a real tonic for health, says UCLH arts curator Guy Noble.

• Dr Katherine Clesham

  Dr Katherine Clesham is a consultant haematologist specialising in the treatment of teenagers and young adults with acute leukaemia and patients undergoing stem cell transplantation and CAR-T therapy.

• Oxbryta (Voxelotor) withdrawal from the UK market in the treatment of Sickle Cell Disorder in people aged 12 years and older

  Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.

• Gender Identity Development Service – legal update 26 March 2021

  The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.

• Towards net zero - estates, facilities, technology and transport

  As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.

• Patients more likely to be admitted to critical care after surgery if a bed is available

  Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.

• Aftercare Guidance Following an Intrathecal Baclofen Pump Implant

  Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.

• Discontinuation of MiniMed™ Mio™ Infusion sets

  Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.